The recent studies that reported a high frequency of autoantibodies recognizing the GluA3 subunit of AMPAR (anti-GluA3 Abs) in patients with FTD [1,53] also corroborated the evidence for altered glutamatergic transmission in this disorder [55,66]. The gene discussed is GRIA3; the disease is frontotemporal dementia.